SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-233906
Filing Date
2012-05-15
Accepted
2012-05-15 13:52:08
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d333861d10q.htm 10-Q 494656
2 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302 d333861dex311.htm EX-31.1 6415
3 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 302 d333861dex312.htm EX-31.2 6439
4 CERTIFICATION OF THE COMPANY'S CEO AND CFO PURSUANT TO SECTION 906 d333861dex321.htm EX-32.1 5422
  Complete submission text file 0001193125-12-233906.txt   1522925

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tspt-20120331.xml EX-101.INS 168954
6 XBRL TAXONOMY EXTENSION SCHEMA tspt-20120331.xsd EX-101.SCH 8388
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tspt-20120331_cal.xml EX-101.CAL 23432
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tspt-20120331_lab.xml EX-101.LAB 74162
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tspt-20120331_pre.xml EX-101.PRE 49418
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51967 | Film No.: 12843114
SIC: 2834 Pharmaceutical Preparations